Max Healthcare Insititute Limited
14
0
0
4
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 45/100
0.0%
0 terminated/withdrawn out of 14 trials
100.0%
+13.5% vs industry average
0%
0 trials in Phase 3/4
25%
1 of 4 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (14)
The Effect of Virtual Reality Distraction on Pain During Colonoscopy
Role: lead
A Prospective Study to Evaluate Clinical Performance of Thermalytix in Detecting Breast Cancers
Role: collaborator
Performance Evaluation of Diagnostic Accuracy of PanTum Detect Test for Detection of Solid Tumours in Known Cancer Population and in Cancer Free Population.
Role: lead
Issues and Challenges in Cancer Patients on Active Treatment During the COVID-19 Pandemic
Role: lead
Assess the Seroconversion Status of Health Care Workers Suspected or Confirmed Cases of COVID-19 Patients
Role: lead
Assess the Safety and Efficacy of Convalescent Plasma to Limit COVID-19 Associated Complications
Role: lead
Anxiety And Depression During COVID-19 IN INDIA
Role: lead
Impact of COVID-19 Pandemic on the Psychological Wellbeing of Healthcare Professionals in India
Role: lead
To Study the Clinical Characteristics and Treatment Outcome of COVID-19 Patients Admitted in Hospitals of Max Healthcare (SCOPe Study)
Role: lead
Radiographic Findings and Their Temporal Changes in COVID-19 Positive Changes Patients: A Prospective Study
Role: lead
COVID-19 and Liver Injury in Patients With or Without Underlying Liver Disease: A Multi-centre Retrospective-prospective Observational Study
Role: lead
Max Ivermectin- COVID 19 Study Versus Standard of Care Treatment for COVID 19 Cases. A Pilot Study
Role: lead
Prospective Interventional Study on Reversibility of Type 2 Diabetes Mellitus With Hypocaloric Diet
Role: lead
Max COVID19- Study
Role: lead
All 14 trials loaded